Interestingly, pharmacological inhibitors of IKBKE are used in treatment of asthma, allergic rhinitis and aphthous ulcers (18,19) and a potential role for these inhibitors has also been identified in obesity related metabolic disorders (20), lung cancer (21) and glioblastoma (13). The gene discussed is IKBKE; the disease is allergic rhinitis.